π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a phase one study to assess the safety of daily dosing of Lactobaci...
Status
Completed
Location
Community of Santa Clara
Start Date
2010-02
Trial ID
NCT00774163
Treatments Being Tested
This randomized dose-ranging study will evaluate the safety, tolerability, ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01520116
The purpose of this study is to assess the ocular comfort and safety of olo...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01326858
The purpose of this study is to compare the safety and preliminary efficacy...
Status
Completed
Location
Chiba University Hospital
Start Date
2019-05-23
Trial ID
NCT03955315
The goal of this randomized clinical trial is to learn if topical treatment...
Status
Recruiting
Location
Genesis Cancer and Blood Institute
Start Date
2025-08-25
Trial ID
NCT06830863
The first testing of TargomiRs in the human setting: dose-finding studies i...
Status
Completed
Location
Concord Repatriation General Hospital
Start Date
2014-09
Trial ID
NCT02369198
Treatments Being Tested
Dyspepsia refers to chronic or recurrent upper gastrointestinal (GI) sympto...
Status
Recruiting
Location
KU Leuven
Start Date
2024-10-01
Trial ID
NCT06482671
Treatments Being Tested
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
This study is designed to investigate the efficacy, safety and tolerability...
Status
Unknown
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02395549
Treatments Being Tested
Demonstrate the safety and efficacy of NB-001 in subjects with recurrent he...
Status
Completed
Location
Radiant Research, Inc
Start Date
2011-04
Trial ID
NCT01321359
Treatments Being Tested